Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Perera, Nirma D ^a   Sheean, Rebecca K ^a   Scott, John W ^a   Kemp, Bruce E ^a   Horne, Malcolm K ^a   Turner, Bradley J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; TAR DNA BINDING PROTEIN; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; DNA BINDING PROTEIN; MUTANT PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 2; PROTEIN TDP-43; RIBONUCLEOTIDE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL GRANULE; CONTROLLED STUDY; ENERGY METABOLISM; KIDNEY; LIVER; MOTONEURON; MOUSE; MOUSE MODEL; MUSCLE ATROPHY; NERVE DEGENERATION; NONHUMAN; PROTEIN PHOSPHORYLATION; SPINAL CORD; TRANSGENIC MOUSE; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CELL LINE; DISEASE MODEL; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BRAIN; CELL LINE; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ENZYME ACTIVATION; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR NEURONS; MUTANT PROTEINS; PROTEIN PHOSPHATASE 2; RIBONUCLEOTIDES; SPINAL CORD; SUPEROXIDE DISMUTASE;

EID: 84897101638     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090449     Document Type: Article

References (34)

1. Ferraiuolo L, Higginbottom A, Heath PR, Barber S, Greenald D, et al. (2011) Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 134: 2627-41.
2. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ (2011) Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol 7: 616-30.
3. Shaw PJ, Eggett CJ (2000) Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol 247: I17-27.
4. Dupuis L, Pradat PF, Ludolph AC, Loeffler JP (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10: 75-82.
5. Kong J, Xu Z (1998) Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1. J Neurosci 18: 3241-50. (Pubitemid 28186017)
6. Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM (1999) Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death.Ann Neurol 46: 787-90. (Pubitemid 29518143)
7. Shaw PJ, Eggett CJ (2000) Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis. J Neurol 247: I17-27.
8. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, et al. (1999) Nutritional status is a prognostic factor for survival in ALS patients. Neurology 53: 1059-1063. (Pubitemid 29442123)
9. Vaisman N, Lusaus M, Nefussy B, Niv E, Comaneshter D, et al.(2009)Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs? J Neurol Sci 279: 26-29.
10. Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, et al. (2001) Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr 74: 328-334. (Pubitemid 32802018)
11. Funalot B, Desport JC, Sturtz F, Camu W, Couratier P (2009) High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler10: 113-117.
12. Dupuis L, Oudart H, Rene F, Gonzalez de Aguilar JL, Loeffler JP (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci USA 101: 11159-11164. (Pubitemid 38989600)
13. Browne SE, Yang L, DiMauro JP, Fuller SW, Licata SC, et al. (2006) Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol Dis 22: 599-610. (Pubitemid 43832131)
14. Dodge JC, Treleaven CM, Fidler JA, Tamsett TJ, Bao C, et al. (2013) Metabolic signatures of amyotrophic lateral sclerosis reveal insights into disease pathogenesis. Proc Natl Acad Sci US A 110: 10812-7.
15. Hamadeh MJ, Tarnopolsky MA (2006) Transient caloric restriction in early adulthood hastens disease endpoint in male, but not female, Cu/Zn-SOD mutant G93A mice. Muscle Nerve 34: 709-719. (Pubitemid 44877554)
16. Patel BP, Safdar A, Raha S, Tarnopolsky MA, Hamadeh MJ (2010) Caloric restriction shortens lifespan through an increase in lipid peroxidation, inflammation and apoptosis in the G93A mouse, an animal model of ALS. PLoS One 5: e9386.
17. Chiang PM, Ling J, Jeong YH, Price DL, Aja SM, et al. (2010) Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. ProcNatl Acad Sci USA 107: 16320-16324.
18. Stallings NR, Puttaparthi K, Dowling KJ, Luther CM, Burns DK, et al. (2013) TDP-43, an ALS linked protein, regulates fate deposition and glucose homeostasis. PLoS One 8:e71793.
19. Li J, McCullough LD (2010) Effects of AMP-activated protein kinase in cerebral ischemia. J Cerebral Blood Flow Metabol 30: 480-492.
20. Ravnskjaer K, Boergesen M, Dalgaard LT, Mandrup S (2006) Glucose-induced repression of PPARalpha gene expression in pancreatic beta-cells involves PP2A activation and AMPK inactivation. J Mol Endocrinol 36: 289-299.
21. Sanders MJ, Grondin PO, Hegarty BD, Snowden MA, Carling D (2007) Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 403:139-48. (Pubitemid 46569875)
22. Garcia-Haro L, Garcia-Gimeno MA, Neumann D, Beullens M, Bollen M, et al. (2010) The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 beta cells. FASEB J 24:5090-5091.
23. Voss M, Paterson J, Kelsall IR, Martín-Granados C, Hastie CJ, et al. (2011) Ppm1E is an in cellulo AMP-activated protein kinase phosphatase. Cell Signal 23:114-24.
24. Turner BJ, Atkin JD, Farg MA, Zang DW, Rembach A, et al. (2005) Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J Neurosci 25: 108-17. (Pubitemid 40110771)
25. Atkin JD, Farg MA, Turner BJ, Tomas D, Lysaght JA, et al. (2006) Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J Biol Chem 281: 30152-65. (Pubitemid 44537023)
26. Soo KY, Atkin JD, Horne MK, Nagley P. (2009) Recruitment of mitochondria into apoptotic signaling correlates with the presence of inclusions formed by amyotrophic lateral sclerosis-associated SOD1 mutations. J Neurochem 108: 578-90.
27. Kaneb HM, Sharp PS, Rahmani-Kondori N, Wells DJ (2011) Metformin treatment has no beneficial effect in a dose response survival study in the SOD1G93A mouse model of ALS. PLoS One 6: e24189.
28. Lim MA, Selak MA, Xiang Z, Krainc D, Neve RL, et al. (2012) Reduced activity of AMP-activated protein kinase protects against genetic models of motor neuron disease. J Neurosci 32: 1123-41.
29. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264: 1772-1775. (Pubitemid 24227760)
30. Guo Y, Wang Q, Zhang K, An T, Shi P, et al. (2012) HO-1 induction in motor cortex and intestinal dysfunction in TDP-43 A315T transgenic mice. Brain Res 15: 88-95.
31. Esmaeili MA, Panahi M, Yadav S, Hennings L, Kiaei M (2013) Premature death of TDP-43 (A315T) transgenic mice due to gastrointestinal complications prior to development of full neurological symptoms of amyotrophic lateral sclerosis. Int J Exp Pathol 94:56-64.
32. Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci USA 106: 18809-14.
33. Wang T, Yu Q, Chen J, Deng B, Qian L, et al. (2010) PP2A mediated AMPK inhibition promotes HSP70 expression in heat shock response. PLoS One 5:e13096.
34. Meyerowitz J, Parker SJ, Vella LJ, Ng DCh, Price KA, et al. (2011) C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol Neurodegener 6: 57.